Page last updated: 2024-08-17

cysteamine and Hepatitis

cysteamine has been researched along with Hepatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barlow, SE; Brunt, EM; Clark, JM; Doo, E; Jain, AK; Karpen, SJ; Kleiner, DE; Kohli, R; Lavine, JE; Molleston, JP; Murray, KF; Neuschwander-Tetri, BA; Rosenthal, P; Schwimmer, JB; Tonascia, J; Van Natta, ML; Vos, MB; Whitington, PF; Wilson, LA; Xanthakos, SA	1

Trials

1 trial(s) available for cysteamine and Hepatitis

Article	Year
In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology, 2016, Volume: 151, Issue:6 Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Body Weight; Child; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis; Humans; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Severity of Illness Index	2016

Article

Year

In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.

Gastroenterology, 2016, Volume: 151, Issue:6

Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Body Weight; Child; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis; Humans; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Severity of Illness Index

2016